Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis

NKILA is a novel suppressor of local recurrence in women breast malignant phyllodes tumor patients via inhibition of the NF-κB pathway

“…These data indicated that NKILA plays an important molecular role in the progression of BMPT recurrence. At present, there is no effective adjuvant therapy, including chemotherapy and radiotherapy, for BMPT, especially for patients who experience BMPT recurrence [ 17 ]. The present study assessed whether NKILA overexpression enhances the sensitivity of primary BMPT recurrent cells to cisplatin.…”